Publication

Symptom severity impacts sympathetic dysregulation and inflammation in post-traumatic stress disorder (PTSD)

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Ida Fonkoue, Emory UniversityPaul J. Marvar, George Washington UniversitySeth Norrholm, Emory UniversityYunxiao Li, Emory UniversityMelanie L. Kankam, Emory UniversityToure N. Jones, Emory UniversityMonica Vemulapalli, Emory UniversityBarbara Rothbaum, Emory UniversityJames Bremner, Emory UniversityNgoc-Anh Le, Atlanta Veterans Affairs Health Care SystemJeanie Park, Emory University
Language
  • English
Date
  • 2020-01-01
Publisher
  • ACADEMIC PRESS INC ELSEVIER SCIENCE
Publication Version
Copyright Statement
  • 2019
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 83
Start Page
  • 260
End Page
  • 269
Grant/Funding Information
  • This work was supported by Merit Review Award number I01CX001065 from the United States Department of Veterans Affairs (VA) Clinical Sciences Research and Development Program; American Heart Association National Affiliate, Collaborative Sciences Award 15CSA24340001; National Institutes of Health (NIH) R01 HL135183; NIH training grant T32 DK-00756; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development and the Clinical Studies Center of the Atlanta VA Health Care System, Decatur, Georgia; and Foundation for Atlanta Veterans Education and Research (FAVER).
Abstract
  • Post-traumatic stress disorder (PTSD) is associated with a greater risk of incident hypertension and cardiovascular disease. Inflammation, impaired baroreflex sensitivity (BRS) decreased parasympathetic nervous system (PNS) and overactive sympathetic nervous system (SNS) activity are suggested as contributing mechanisms. Increasing severity of PTSD symptoms has been linked to greater cardiovascular risk; however, the impact of PTSD symptom severity on inflammation and autonomic control of blood pressure has not yet been explored. We hypothesized that increasing PTSD symptom severity is linked to higher inflammation, greater SNS activity, lower PNS reactivity and impaired BRS. Seventy Veterans participated in this study: 28 with severe PTSD ((Clinical Administered PTSD Scale (CAPS) > 60; S-PTSD), 16 with moderate PTSD (CAPS ≥ 45 ≤ 60; M-PTSD) and 26 Controls (CAPS < 45; NO-PTSD). We recorded continuous blood pressure (BP), heart rate (HR) via EKG, heart rate variability (HRV) markers reflecting PNS and muscle sympathetic nerve activity (MSNA) at rest, during arterial baroreflex sensitivity (BRS) testing via the modified Oxford technique, and during 3 min of mental stress via mental arithmetic. Blood samples were analyzed for 12 biomarkers of systemic and vascular inflammation. While BP was comparable between severity groups, HR tended to be higher (p = 0.055) in S-PTSD (76 ± 2 beats/min) than in Controls (67 ± 2 beats/min) but comparable to M-PTSD (70 ± 3 beats/min). There were no differences in resting HRV and MSNA between groups; however, cardiovagal BRS was blunted (p = 0.021) in S-PTSD (10 ± 1 ms/mmHg) compared to controls (16 ± 3 ms/mmHg) but comparable to M-PTSD (12 ± 2 ms/mmHg). Veterans in the S-PTSD group had a higher (p < 0.001) combined inflammatory score compared to both M-PTSD and NO-PTSD. Likewise, while mental stress induced similar SNS and cardiovascular responses between the groups, there was a greater reduction in HRV in S-PTSD compared to both M-PTSD and NO-PTSD. In summary, individuals with severe PTSD symptoms have higher inflammation, greater impairment of BRS, a trend towards higher resting HR and exaggerated PNS withdrawal at the onset of mental stress that may contribute to cardiovascular risk in severe PTSD.
Author Notes
  • Jeanie Park, M.D., Associate Professor.
Keywords
Research Categories
  • Health Sciences, Immunology
  • Biology, Neuroscience
  • Psychology, Clinical

Tools

Relations

In Collection:

Items